Clinical Trial Update: Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from Phase 1 and Phase 2 studies evaluating DN101 in combination with Taxotere (docetaxel) for patients with advanced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DN101 (calcitriol)
• Taxotere (docetaxel)

Snippet

Sponsor: Novacea | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1, Phase 2 | Status: COMPLETED